Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Dow
Medtronic
Harvard Business School
Moodys

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

ORAGRAFIN CALCIUM Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Oragrafin Calcium, and what generic alternatives are available?

Oragrafin Calcium is a drug marketed by Bracco and is included in one NDA.

The generic ingredient in ORAGRAFIN CALCIUM is ipodate calcium. There is one drug master file entry for this compound. Additional details are available on the ipodate calcium profile page.

Summary for ORAGRAFIN CALCIUM
US Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
DailyMed Link:ORAGRAFIN CALCIUM at DailyMed
Drug patent expirations by year for ORAGRAFIN CALCIUM

US Patents and Regulatory Information for ORAGRAFIN CALCIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco ORAGRAFIN CALCIUM ipodate calcium GRANULE;ORAL 012968-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Colorcon
Express Scripts
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.